Posted on 13th August 2012

FORT LAUDERDALE, FL–(Marketwire -08/13/12)- SkinPro, the makers of award-winning cosmeceuticals, have reported to iPopularity this morning that they have received a notice informing them that the importation and registration of Elite Serum has been officially blocked in China. While Chinese health officials have declined to comment on this matter, persons with information related to the documentation filing have stated that Elite Serum was deemed simply “too strong” to be classified as an OTC cosmetic product and can only be available by prescription in China. This is due to the extremely high concentration of the patented wrinkle fighting peptides, Argireline and Matrixyl 3000.

Richard Banks, spokesperson for SkinPro, stated, “after performing all the required due diligence with our prospective distribution partner in China, it was determined that the Chinese officials have classified Elite Serum as a ‘drug.'” Manufactured under FDA registration number 3002692859 in the United States, Elite Serum is considered by industry observers to be the first real alternative to botulinum toxin injections. These popular procedures are designed to fill in wrinkles and fine lines around the eyes and are administered by plastic surgeons in thousands of locations worldwide. These injections are more popularly known by their brand names, as Botox, Restylane and Juvederm.

Due to the high cost, and most importantly the safety concerns surrounding these procedures, SkinPro set out to develop a topical alternative that maintained the same properties as their injectable counterparts. The only difference was that Elite Serum did not require an injection and it can be administered by the user like any other eye serum or eye cream product. So far, despite lobbying by plastic surgery associations and the mega pharmaceutical conglomerates, the public’s response to Elite Serum has been nothing short of extraordinary.

iPopularity follows the hottest trending topics on the internet. Elite Serum has been on the radar since January of this year. This surge in popularity follows a program by Dr. Oz where he recommended use of an eye treatment with Argireline as a legitimate alternative to Botox. Given that Elite Serum contains such an overwhelming amount of Argireline and other wrinkle fighting peptides, the public was immediately attracted towards this product and have been expressing their interest and satisfaction in various social media outlets throughout the internet. For instance, the Facebook page for Elite Serum currently has over 45,000 ‘likes.’ This is a measurement of trend strength that iPopularity closely follows and this shows the overwhelming public embracement of Elite Serum.

While the importation of Elite Serum to China is now officially banned due to the high concentration of pharmaceutical grade actives, Richard Banks has informed iPopularity that the company has had tremendous success throughout South East Asia, particularly in Singapore, Malaysia and the Philippines. The formula is well received and local licensing deals are underway with significant and well funded medical distribution partners. Accordingly, SkinPro expects to release this information during an upcoming investor presentation planned for this fall at their South Florida headquarters. Be sure to keep following iPopularity to find out what is trending now on the internet.